These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27427223)

  • 21. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
    Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
    Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features of leiomyosarcoma of the urinary bladder: analysis of 183 cases.
    Rodríguez D; Preston MA; Barrisford GW; Olumi AF; Feldman AS
    Urol Oncol; 2014 Oct; 32(7):958-65. PubMed ID: 25027684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.
    Liu XY; Jiang YZ; Liu YR; Zuo WJ; Shao ZM
    Medicine (Baltimore); 2015 Aug; 94(31):e1309. PubMed ID: 26252312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.
    Fairey AS; Kassouf W; Aprikian AG; Chin JL; Izawa JI; Fradet Y; Lacombe L; Rendon RA; Bell D; Cagiannos I; Drachenberg DE; Lattouf JB; Estey EP
    Urol Oncol; 2012; 30(6):825-32. PubMed ID: 21889368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment outcomes.
    Arshi A; Tajudeen BA; St John M
    Oral Oncol; 2015 Dec; 51(12):1088-94. PubMed ID: 26442813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
    Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
    Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
    J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary adenocarcinoma of the urinary bladder: a single site analysis of 21 cases.
    Zhang H; Jiang H; Wu Z; Fang Z; Fan J; Ding Q
    Int Urol Nephrol; 2013 Feb; 45(1):107-11. PubMed ID: 23054322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer.
    Wang L; Zhao J; Yang C; Kuang R; Kazobinka G; Pang Z; Hou T
    Cell Physiol Biochem; 2018; 48(6):2364-2373. PubMed ID: 30114689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study.
    Anderström C; Johansson SL; von Schultz L
    Cancer; 1983 Oct; 52(7):1273-80. PubMed ID: 6883290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.
    Lee RJ; Arshi A; Schwartz HC; Christensen RE
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):470-7. PubMed ID: 25811167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients.
    van Onna IE; Oddens JR; Kok ET; van Moorselaar RJ; Bosch JL; Battermann JJ
    Eur Urol; 2009 Jul; 56(1):113-21. PubMed ID: 18722048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cancer of the urachus. A rare form of tumors of the bladder].
    Vergos M; Messina MH; Lhomme Desages B; Chapuis O
    J Urol (Paris); 1992; 98(1):56-9. PubMed ID: 1527402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA; MaDan OP; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urachal carcinoma: a pathologic and clinical study of 46 cases.
    Dhillon J; Liang Y; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2015 Dec; 46(12):1808-14. PubMed ID: 26364859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.
    Siefker-Radtke AO; Gee J; Shen Y; Wen S; Daliani D; Millikan RE; Pisters LL
    J Urol; 2003 Apr; 169(4):1295-8. PubMed ID: 12629346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.